Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  recombinant human hyaluronidase
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Recombinant Human Hyaluronidase in Treating Lymphedema in Patients with Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: Not specified
Trial IDs: BRS0032, NCI-2013-01624, 4593, NCT01928030
A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CR107838, NCI-2016-00594, 2015-001210-94, 54767414MMY1004, NCT02519452
Start Over